Though much of the dust has settled around Novo Nordisk and Eli Lilly’s crusade against compounded GLP-1s, the recent ...

The stock's fall snapped a four-day winning streak.

In a breakthrough for incretin medicines, China’s National Medical Products Administration (NMPA) has approved Innovent’s ...

Taking to platforms including Reddit and Telegram for guidance, buyers import small quantities, often described as research ...

There is a bottomless appetite for news about weight-loss drugs. We cannot hear enough about the celebrities, politicians and ...

In the race to make the most tolerable obesity drug, there seems to be no clear winner—at least not according to analysts ...

SAN FRANCISCO (Reuters) -In what she calls the "wild west" of obesity medicines, Missouri-based Amy Spencer is a pioneer.

Eli Lillys Mounjaro KwikPen gains approval in India, targeting diabetes and obesity with its dual-action formula for weight ...

The RABBIT registry is supported by a joint, unconditional grant from AbbVie, Alfasigma, Amgen, Biocon, Bristol Myers Squibb, ...

Lilly King Gets One More Win at Indy Summer Cup; Regan Smith Drops 56.5 100 Fly Soon-to-be retired Lilly King got one more ...

A federal judge ruled that the government did not violate the law in a dispute with J&J over the 340B drug discount program.

At his Paris Fashion Week show, the designer debuted an expansive womenswear collection featuring bright color, bold ...